Late-Breaking Trials in axSpA and PsA https://t.co/EWeF0nkb1h https://t.co/HgY0be0PDX https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Tue, 11/11/2025 – 16:00 RheumNow Dr. John Cush Late-Breaking Trials […]
Diagnostic Delays in PsA: A Radiographic Perspective Dr. Brian Jaros reports on abstract 1713 (Diagnostic Delay in Pso https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
S.Korean study of 481 pts w/ myositis (IIM) – 12.9% (n = 62) had myositis-assoc. cancer. CA risk factos= older age, https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
DAHLIAS study – Nipocalimab in Sjögren’s Disease jjcush@gmail.com Tue, 11/11/2025 – 13:47
Genentech announced positive results from the phase III DBRPCT ALLEGORY trial showin safety & efficacy of obinutuzu https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Tue,
Systematic review of 10 studies showed TNFi exposure in utero not assoc w/ incr risk of infant severe infxn (4
Tapering in SELECT GCA: Steroids are the Problem Dr. Mike Putman reports on abstract 0895 (Impact of Glucocorticoid Ta https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
Combining CAR-T with CAR-Treg All in One Dr. Alfred Kim reports on abstract 0981 (GNTI-350: A CAR-Treg Therapy Offerin https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
Bone Density in Ankylosing Spondylitis At #ACR25, a retrospective study from China tackled this challenge using quanti https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Tue,
#ACR25 RA Topic Panel A focused conversation on the latest in psoriatic arthritis care — from emerging data and trea
In 2024, 77 pts referred to Rheum for possible PMR were ultimately Dx w/ B19 viral infx. 96% had arthralgia
Genetic Risks and Severe Cutaneous Reactions to Allopurinol jjcush@gmail.com Mon, 11/10/2025 – 17:02
New ACR 2025 Guidelines for Non-Renal Lupus jjcush@gmail.com Mon, 11/10/2025 – 16:44
There is a growing burden of #OA among middle-aged adults, rising by 123.7%, from 11.8 million in 1990 to 26.4
20-40% of Autoimmune hepatitis (AIH) is associated with other autoimmune diseases – lead by autoimmune thyroiditis, type https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Mon,
Sjogren’s disease: two drugs with positive trials Sjogren’s disease: two drugs with positive trials After several https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Mon, 11/10/2025
RETREAT study was a 12 wk RCT of Tai Chi in 178 knee OA pts Rx w/ online OA info
Off the Shelf: CAR-T Dr. Akhil Sood reports on abstract 0663 (iPSC-Derived Off-the-Shelf anti-CD19 CAR T cells Deliver https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
AI in Fellow Recruitment: A New Dawn in Medical Education? Drs. Mrinalini Dey and Bharat Kumar abstract 2174 (Using Na
Beyond the Breakthrough: Equity and Access in CAR-T Cell Therapy for RA At #ACR25, abstract 1039, “Global Cost-Effecti https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
“It is not the strongest of the species that survive, nor the most intelligent, but the one most responsive to
Beyond the Breakthrough: Equity and Access in CAR-T Cell Therapy for RA At #ACR25, abstract 1039 entitled, “Global https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
IL-23 Blockade Goes Oral A new player is entering the IL-23 arena — and it’s a tablet! Icotrokinra (ICO), a
Stopping therapy in GCA At #ACR25 we saw the SELECT-GCA extension data presented in the first plenary session, looking https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
The Interview jjcush@gmail.com Fri, 11/07/2025 – 18:11 Education/ACR/EULAR Economics Wisdom Is Featured Off Show Author Off PDQ Off
The Interview (11.7.2025) jjcush@gmail.com Fri, 11/07/2025 – 18:00
Weight Loss as a Therapeutic Goal in PsA PsA is a complex inflammatory disease often complicated by obesity, which not
